SOMERSHAM, England and SAN DIEGO, June 13, 2023 /PRNewswire/ — Today, DARPA, Siemens, US ARMY, Georgia Tech Research Institute, and Paragraf – through recently acquired Cardea Bio, now Paragraf San Diego – presented novel multiomics […]
On Monday night, Biogen announced a change to its board to add Susan Langer as a director, as longtime member Alex Denner and two others leave the board. While Langer has a long resume in […]
Biogen’s big top-level shakeup continued Monday evening with news that Alex Denner — first elected to the board back in 2009 when he spearheaded Carl Icahn’s bid to engineer a tumultuous turnaround — is following […]
Cascade AIDS Project has hired a well-known nonprofit veteran as its new CEO. Click here to view original post Click here to view original post
SAN DIEGO–(BUSINESS WIRE)– #biotechnews–Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, today announced […]
The total purchase price for the Seattle-based biotech could go as high as $3.5 billion if it hits certain milestones for its lead drug candidate. Click here to view original post Click here to view […]
Montefiore Medical Center in New York performed the first global implantation of the new BIOMONITOR IV ICM LAKE OSWEGO, Ore., June 12, 2023 /PRNewswire/ — BIOTRONIK, a leader in implantable medical device technology, today announced […]
Alvotech and partner Teva have now conquered half the hurdle in bringing a Stelara biosimilar to market. The two companies announced Monday that they agreed to a settlement and license agreement with Johnson & Johnson […]
LA JOLLA—The cellular life inside a plant is as vibrant as the blossom. In each plant tissue—from root tip to leaf tip—there are hundreds of cell types that relay information about functional needs and environmental […]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $SPRB–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted […]
© 2023 Biotech Networks, LLC
